Author
Maria Lagadinou
Also Known As
M Lagadinou, M. Lagadinou, MARIA LAGADINOU, Maria Lagadinou
73
Publications
1K
Citations
18
H-Index
59
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 8 | 8 | 227 |
2 | Public Health | 3 | 3 | 68 |
3 | Emergency Medicine | 2 | 2 | 45 |
4 | Engineering | 1 | 1 | 40 |
5 | Health Sciences | 1 | 1 | 11 |
Maria Lagadinou
×
17
Publications
466
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
2010 | 70 | |
2020 | 57 | |
2021 | 52 | |
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial Τheodoros Karampitsakos, Panagiota Tsiri, Matthaios Katsaras, Clinical Microbiology and Infection Open LabelTocilizumab Versus BaricitinibClinical Infectious DiseaseCovid-19 PandemicClinical Trials | 2022 | 42 |
2023 | 40 | |
2020 | 33 | |
2023 | 33 | |
2013 | 23 | |
2021 | 18 | |
2013 | 14 |
Page 1
Page 1